Laboratory variables and treatment adequacy in hemodialysis patients in Iran.
This study aims to evaluate the laboratory variables in Iranian hemodialysis pa-tients. We studied 338 patients in 6 dialysis centers around the country. Sixty four percent of the patients were anemic, and the mean of hemoglobin levels in the patients was 9.6 +/- 1.9 g/dL. Women had a significantly higher prevalence of anemia (p= 0.004); however, considering the absolute hemoglobin values, there was no significant difference between genders (p> 0.05). The mean urea reduction ratio (URR) and Kt/V in the patients were 62.6 +/- 12.8 and 1.17 +/- 0.31, respectively. Hyperphosphatemia and hyperkalemia were observed in 50% and 58%, respectively. We conclude that our study demonstrated a relatively high prevalence of anemia and hyper-phosphatemia, however, a surprisingly good dialysis urea clearance in the Iranian hemodialysis patients. We should exploit more effort to maintain hemoglobin and serum phosphate levels with-in the target ranges.
Pourfarziani
Vahid
V
Nephrology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Ghanbarpour
Fahimeh
F
Nemati
Eghlim
E
Taheri
Saeed
S
Einollahi
Behzad
B
D000740:Anemia / Q000188:drug therapy / Q000453:epidemiology; D001774:Blood Chemical Analysis; D001835:Body Weight; D003430:Cross-Sectional Studies; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007492:Iran; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status; D015995:Prevalence; D006435:Renal Dialysis / Q000379:methods* / Q000592:standards; D012727:Sex Characteristics
D004921:Erythropoietin